Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 12/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR1D | P28221 | 3/20 | 0.39 |
| ▸ | HTR1A | P08908 | 2/20 | 0.39 |
| ▸ | DRD2 | P14416 | 2/20 | 0.39 |
| ▸ | HTR1B | P28222 | 2/20 | 0.39 |
| ▸ | HTR1F | P30939 | 2/20 | 0.39 |
| ▸ | HTR7 | P34969 | 2/20 | 0.39 |
| ▸ | DRD3 | P35462 | 2/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | HTR1E | P28566 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3167331 | 0.92 | HTR6 (0.46) | HTR6HTR2AHTR1DHTR1ADRD2 | |
| SCHEMBL1163485 | 0.84 | HTR2A (0.50) | HTR6HTR2AHTR1DTRPM8EGFR | |
| SCHEMBL17147641 | 0.83 | HTR2A (0.49) | HTR6HTR2AHTR1DTRPM8EGFR | |
| SCHEMBL1163144 | 0.82 | HTR2A (0.48) | HTR6HTR2AHTR1DTRPM8 | |
| SCHEMBL3804876 | 0.82 | HTR2A (0.48) | HTR6HTR2AHTR1DTRPM8EGFR | |
| SCHEMBL3182087 | 0.81 | HTR2A (0.47) | HTR6HTR2AHTR1DDRD2TRPM8 | |
| SCHEMBL3182668 | 0.81 | HTR6 (0.50) | HTR6HTR2AHTR1DHTR1ADRD2 | |
| SCHEMBL16509893 | 0.80 | HTR2A (0.47) | HTR6HTR2AHTR1DTRPM8 | |
| SCHEMBL3806838 | 0.80 | HTR2A (0.47) | HTR6HTR2AHTR1DTRPM8 | |
| SCHEMBL3183284 | 0.79 | HTR2A (0.46) | HTR6HTR2AHTR1DTRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8071786-B2 | Indole compounds useful as serotonin selective agents | GALENEA CORP. (US) | 2011-12-06 | — | — | US | disclosed |
| US-8071786-B2 | Indole compounds useful as serotonin selective agents | GALENEA CORP. (US) | 2011-12-06 | — | — | US | disclosed |
| US-8071786-B2 | Indole compounds useful as serotonin selective agents | GALENEA CORP. (US) | 2011-12-06 | — | — | US | disclosed |
| US-20100137616-A1 | INDOLE COMPOUNDS USEFUL AS SEROTONIN SELECTIVE AGENTS | SARD HOWARD P | 2010-06-03 | — | — | US | disclosed |
| US-7655691-B2 | Indole compounds useful as serotonin selective agents | ORGANIX, INC. | 2010-02-02 | — | — | US | disclosed |
| EP-1799640-A4 | INDOLE COMPOUNDS USEFUL AS SEROTONIN SELECTIVE AGENTS | ORGANIX INC (US) | 2009-09-02 | — | — | EP | disclosed |
| EP-1799640-A2 | INDOLE COMPOUNDS USEFUL AS SEROTONIN SELECTIVE AGENTS | Organix, Inc. (US) | 2007-06-27 | — | — | EP | disclosed |
| US-20060100266-A1 | Indole compounds useful as serotonin selective agents | ORGANIX, INC. (US) | 2006-05-11 | — | — | US | disclosed |
| WO-2006047032-A2 | INDOLE COMPOUNDS USEFUL AS SEROTONIN SELECTIVE AGENTS | ORGANIX, INC. (US) | 2006-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137616-A1 | INDOLE COMPOUNDS USEFUL AS SEROTONIN SELECTIVE AGENTS | TPH1, TPH2, AANAT | HTR6 4/4885HTR2A 11/4885HTR1D 21/4885 |
| US-20060100266-A1 | Indole compounds useful as serotonin selective agents | TPH1, TPH2, AANAT | HTR6 4/4885HTR2A 11/4885HTR1D 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.